Skip to main content
See every side of every news story
Get Started
SubscribeLogin
CureVac image

News from CureVac

Top CureVac News

Curevac Publishes Financial Results for the Second Quarter as Well as the First Half of 2025 and Informs About Its Business Development
Tübingen · Tübingen

Curevac Publishes Financial Results for the Second Quarter as Well as the First Half of 2025 and Informs About Its Business Development

Conclusion of a binding purchase agreement, within the framework of which BioNTech intends to acquire all shares in CureVac; merger of two outstandingly complementary German companies to provide patients worldwide with transformative mRNA-based therapies Agreement on the settlement and termination of all pending patent disputes with Pfizer/BioNTech in the USA in connection with mRNA-based COVID-19 vaccines and establishing a framework for the se…Read Article
Curevac Filed a Patent Dispute over Covid-19 Vaccines with Biontech/pfizer
Pfizer · Tübingen

Curevac Filed a Patent Dispute over Covid-19 Vaccines with Biontech/pfizer

Curevac receives a total of 740 million dollars. This was announced by the company based in TübingenSee the Story
You've scrolled to the bottom of the feed, there are no more stories.
News
For You
SearchBlindspotLocal